Has Lawrence Lenke, MD received payments from drug or device companies?

Yes. Drug and device makers reported $26,764,492 in general payments to Lawrence Lenke, MD across 474 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lawrence Lenke, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lawrence Lenke, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lawrence Lenke, MD

Orthopaedic Surgery · New York, NYNPI 1841216165

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $26,000,856 of the $26,764,492 with a category attached, or 97.1%. Medtronic accounts for 98.4% of it on its own, with 6 other manufacturers making up the rest. Among orthopaedic surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$26,764,492in general payments, 2019–2025

Across 474 payments — averaging $56,465 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$26.3M
Acuity Surgical Devices, LLC$436K
Surgical Theater. Inc.$2K
Si-bone, Inc.$303
Synthes GmbH$196
Johnson & Johnson$107
plus $86 from 1 others

$3,625in research payments, 2019–2025

Across 3 payments — averaging $1208.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$4K

What the payments were for

Royalty or licence$26,000,85697%
Consulting fees$263,1881%
Speaking & faculty fees$466,9902%
Travel & lodging$21,5570%
Food & beverage$11,9010%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	459	$26,326,087
Acuity Surgical Devices, LLC	9	$436,096
Surgical Theater. Inc.	1	$1,615
Si-bone, Inc.	2	$303
Synthes GmbH	1	$196
Johnson & Johnson	1	$107
DJO, LLC	1	$86

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

CD HORIZON SPINAL SYSTEM$14,645,626
CD HORIZON$10,017,864
UNID_PASS$102,845
INFINITY OCCIPITOCERVICAL UPPER THORACIC SYSTEM$32,653
MazorX - Renaissance$10,792
DIVERGENCE-L$2,691
DIVERGENCE-L ANTERIOR/OBLIQUE LUMBAR FUSION SYSTEM$2,500
VERTEX RECONSTRUCTION SYSTEM$1,180
MAZOR X SYSTEM$832
iFuse Implant$303
GRAFTONAND GRAFTON PLUSDEMINERALIZED BONE MATRIX (DBM)$177
Mazor X Stealth Edition$175
CRESCENT SPINAL SYSTEM$156
VIPER$107
Vivigen MIS Delivery System$107
Spine & Trauma 3D Navigation$107
CONDUIT$107

How this compares

$26,764,492 in reported general payments places this provider in the 95th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York →

Medicare billing

Part B allowed, 2024

$18,834

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	27	$562
Methocarbamol	11	$362

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in New York

Anthony RomeoNew York$26.8M
Edwin SuNew York$13.2M
William RicciNew York$11.6M
Steven HaasNew York$11.3M
Giles ScuderiNew York$10.7M
Joseph ZuckermanNew York$9.9M
Evan FlatowNew York$9.6M
Bradford ParsonsNew York$9.4M
Geoffrey WestrichNew York$7.1M
Andrew PearleNew York$6.7M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →